Land: Malta
Taal: Engels
Bron: Medicines Authority
VALSARTAN
Actavis Group PTC ehf Revkjavikurvegi 76-78, 220 Hafnarfjordur, Iceland
C09CA03
VALSARTAN 80 mg
CAPSULE
VALSARTAN 80 mg
POM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Withdrawn
2011-12-27
Page 1 of 8 PACKAGE LEAFLET: INFORMATION FOR THE USER VALSARTAN 40 MG CAPSULES VALSARTAN 80 MG CAPSULES VALSARTAN 160 MG CAPSULES Valsartan READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Valsartan Capsules are and what they are used for 2. What you need to know before you take Valsartan Capsules 3. How to take Valsartan Capsules 4. Possible side effects 5. How to store Valsartan Capsules 6. Contents of the pack and other information 1. WHAT VALSARTAN CAPSULES ARE AND WHAT THEY ARE USED FOR Valsartan Capsules contain the active ingredient valsartan. Valsartan belongs to a class of medicines known as angiotensin II receptor antagonists, which help to control high blood pressure. Angiotensin II is a substance in the body that causes the blood vessels to tighten, causing your blood pressure to increase. Valsartan Capsules work by blocking the effect of angiotensin II. As a result, blood vessels relax and blood pressure is lowered. Valsartan 40 mg Capsules can be used to: TREAT HIGH BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE. High blood pressure increases the workload on the heart and arteries. If not treated it can damage the blood vessels of the brain, heart, and kidneys, and may result in a stroke, heart failure, or kidney failure. High blood pressure increases the risk of heart attacks. Lowering your blood pressure to normal reduces the risk of developing these disorders. TREAT ADULT PATIENTS AFTER A RECENT HEART ATTACK (myocardial infarction) . “Recent” means th Lees het volledige document
Page 1 of 19 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Valsartan 40 mg Capsules Valsartan 80 mg Capsules Valsartan 160 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 40 mg Valsartan. Each capsule contains 80 mg Valsartan. Each capsule contains 160 mg Valsartan. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsules, hard Valsartan 40mg Capsules are a hard gelatin, light grey opaque / light grey opaque capsule with ‘VS3’ over ‘ ’ on the cap and no markings on the body. Valsartan 80mg Capsules are a hard gelatin, light grey opaque / flesh opaque capsule with ‘VS2’ over ‘ ’ on the cap and no markings on the body. Valsartan 160mg Capsules are a hard gelatin, dark grey opaque / flesh opaque capsule with ‘VS1’ over ‘ ’ on the cap and no markings on the body. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS VALSARTAN 40MG CAPSULES Hypertension Treatment of hypertension in children and adolescents 6 to 18 years of age. Recent myocardial infarction Treatment of clinically stable adult patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction after a recent (12 hours-10 days) myocardial infarction (see sections 4.4 and 5.1) Page 2 of 19 Heart failure Treatment of adult patients with symptomatic heart failure when ACE-inhibitors are not tolerated or in beta-blocker intolerant patients as add-on therapy to ACE inhibitors when mineralocorticoid receptor antagonists cannot be used (see sections 4.2, 4.4, 4.5 and 5.1). VALSARTAN 80MG AND 160MG CAPSULES Hypertension Treatment of essential hypertension in adults, and hypertension in children and adolescents 6 to 18 years of age. Recent myocardial infarction Treatment of clinically stable adult patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction after a recent (12 hours-10 days) myocardial infarction (see sections 4.4 and 5.1) Heart failure Treatment of adult patients with symptomatic heart fail Lees het volledige document